Clinical Trials on Fluorocholine PET/CT in Germany
Total 71 results
-
University Hospital, EssenRecruitingProstate Cancer | Survivorship | PET/CT | PSMAGermany
-
Bone Therapeutics S.ACompletedBone Fracture | Validation Studies | Fracture Healing | X-Ray | Delayed Union Fracture | CT-scanGermany
-
Das Radiologische ZentrumHeidelberg UniversityRecruiting
-
Georg DultzCompletedPercutaneous Endoscopic Gastrostomy (PEG)Germany
-
University Hospital, EssenCompletedNSCLC | EGFR T790M | FDG-PETGermany
-
Goethe UniversityRecruitingSedation Set-up Time | Additional Time Required for Volatile SedationGermany
-
Ivoclar Vivadent AGActive, not recruitingCaries Pit and Fissure Limited to EnamelGermany, Switzerland
-
BayerCompletedWet Macular DegenerationGermany
-
University of KonstanzCompletedTrauma Treatment | Lifeline NET | Modification of Narrative Exposure TherapyGermany
-
Lund UniversityCharite University, Berlin, Germany; University of Helsinki; Skane University... and other collaboratorsRecruitingBrain Injuries | Biomarkers | Cardiac Arrest | EEG | CT | Neurological OutcomeSweden, Germany, Finland
-
RWTH Aachen UniversityCompletedAdministration of Local Anaesthetics With a Special Atomizing Set Durching Fexible BronchoscopyGermany
-
Ruhr University of BochumUnknownIn the Study the Value of Capnography for Avoiding Complications During Sedation for PEG is Evaluated.Germany
-
BayerRegeneron PharmaceuticalsCompletedWet Age-related Macular DegenerationGermany
-
Johannes Gutenberg University MainzNovartisCompletedNeovascular Age-related Macular DegenerationGermany
-
Novartis PharmaceuticalsCompleted
-
Boehringer IngelheimCompletedWet Macular DegenerationAustria, Germany, Hungary
-
University of Erlangen-NürnbergUnknownPrimary Open Angle Glaucoma | Secondary Open Angle Glaucoma Due to PEXGermany
-
Oraya Therapeutics, Inc.CompletedEye Diseases | Age-Related Macular Degeneration | Macular Degeneration | Retinal Diseases | AMD | Wet AMD | Wet Age-Related Macular DegenerationUnited Kingdom, Czech Republic, Austria, Germany, Italy
-
Boehringer IngelheimCompletedWet Macular DegenerationUnited Kingdom, United States, Germany
-
Ruhr University of BochumRecruiting
-
University Medicine GreifswaldRecruitingMolar Incisor Hypomineralization | Hypersensitive | Pit and Fissure SealantsGermany
-
Imago BioSciences, Inc., a subsidiary of Merck...CompletedMyelofibrosis | Primary Myelofibrosis (PMF) | Post-polycythemia Vera Myelofibrosis (PPV-MF) | Post-essential Thrombocythemia Myelofibrosis (PET-MF)Germany, United States, Australia, Italy, United Kingdom
-
Ruhr University of BochumCompletedTopical 0.05% Clobetasol Propionate in Vaseline Versus UVA-1 Phototherapy in Vulvar Lichen SclerosusVulvar Lichen SclerosusGermany
-
Alkahest, Inc.CompletedNeovascular Age-related Macular DegenerationUnited States, Germany, Poland, Hungary
-
Novartis PharmaceuticalsCompletedNeovascular Age-related Macular DegenerationGermany, United Kingdom
-
Novartis PharmaceuticalsCompletedAge-related Macular DegenerationGermany, Switzerland
-
Novartis PharmaceuticalsTerminatedc-MET Inhibitor; PI3K Inhibitor, PTEN Mutations, Homozygous Del. of PTEN or PTEN Neg. by IHC, c-Met Ampli. by FISH, INC280, BKM120, Buparlisib; Recurrent GBMSpain, Switzerland, Germany, United States, Netherlands
-
Novartis PharmaceuticalsCompletedNeuroendocrine Tumors | Advanced NET of GI Origin | Advanced NET of Lung OriginUnited States, Colombia, Italy, Taiwan, United Kingdom, Belgium, Czechia, Germany, Japan, Saudi Arabia, Canada, Netherlands, Spain, Korea, Republic of, Lebanon, Austria, China, Greece, South Africa, Thailand, Hungary, Turkey, Poland, ... and more
-
Novartis PharmaceuticalsCompletedWell-differentiated Non-functional NET of Thoracic Origin | Well-differentiated Non-functional NET of Gastrointestinal Origin | Well-differentiated Non-functional NET of Pancreatic Origin | Poorly-differentiated Gastroenteropancreatic Neuroendocrine CarcinomaUnited States, Italy, Spain, Japan, Belgium, Netherlands, Germany, France, Canada, Austria, United Kingdom, Australia
-
Novartis PharmaceuticalsCompletedNeovascular Age-Related Macular DegenerationSpain, Italy, Germany, Canada, Ireland
-
Johannes Gutenberg University MainzBayer; Maastricht University; University of Bonn; Siemens Corporation, Corporate... and other collaboratorsRecruitingVenous Thromboembolism (VTE) | Deep Vein Thrombosis (DVT) | Pulmonary Embolism (PE)Germany
-
Kodiak Sciences IncTerminatedWet Macular DegenerationGermany, United States, Latvia, Spain, Czechia, Poland, Slovakia
-
Forma Therapeutics, Inc.RecruitingVery Low Risk, Low Risk, or Intermediate Risk MDS Per IPSS-RUnited States, France, Canada, Germany
-
Hoffmann-La RocheCompletedWet Macular DegenerationUnited Kingdom, Germany, Japan, Netherlands, United States, Canada, Hungary, Italy, Mexico, Poland, Spain, Israel, Russian Federation, Switzerland, Turkey
-
Hoffmann-La RocheCompletedWet Macular DegenerationKorea, Republic of, United States, China, Argentina, Australia, Denmark, France, Germany, Italy, Poland, Spain, Singapore, Austria, Brazil, Hong Kong, Hungary, Portugal, Russian Federation, Taiwan, Turkey, Bulgaria
-
BayerTerminatedMacular DegenerationHong Kong, Korea, Republic of, United States, Canada, Switzerland, Spain, Japan, Italy, Czech Republic, Australia, Austria, Slovakia, Germany, Hungary, Israel, Chile, France, Colombia
-
BayerRecruitingVisual Impairment | Neovascular Age-related Macular Degeneration (nAMD) | Diabetic Macula Edema (DME)Germany, Canada, Denmark, France, Italy, Saudi Arabia, Switzerland, Australia, Finland, Netherlands, Sweden, Norway, United Arab Emirates, Japan, United Kingdom
-
Novartis PharmaceuticalsCompletedNeovascular Age-related Macular DegenerationGermany, Turkey, Austria, Canada, Czechia, United Kingdom, Hungary, Italy, Lithuania, Guatemala, France, Ireland, Argentina, Portugal, Spain, Sweden, Greece, Switzerland, Slovakia, Finland, Netherlands, Colombia, Mexico, Panama
-
AmgenParexelCompletedNeovascular (Wet) Age-related Macular Degeneration (AMD)Spain, United States, Czechia, Serbia, Israel, Canada, Germany, Japan, Hungary, Poland, Korea, Republic of, Estonia, Hong Kong, Italy, Latvia, Lithuania, Mexico, Slovakia
-
SandozCompletedNeovascular Age-related Macular DegenerationUnited States, Bulgaria, Czechia, Australia, Austria, France, Germany, Hungary, Israel, Japan, Latvia, Lithuania, Poland, Portugal, Slovakia, Spain
-
Novartis PharmaceuticalsCompletedNeovascular Age-related Macular DegenerationUnited States, Czechia, Italy, Taiwan, Australia, Israel, Belgium, France, Spain, Germany, Korea, Republic of, Portugal, Sweden, Netherlands, Malaysia, Switzerland
-
Telios Pharma, Inc.RecruitingPrimary Myelofibrosis | Myelofibrosis | Post-PV MF | Post-ET MyelofibrosisSpain, United States, France, Poland, Italy, Germany
-
Chengdu Kanghong Biotech Co., Ltd.TerminatedNeovascular Age-related Macular DegenerationUnited States, Argentina, Australia, Austria, Belgium, Canada, Chile, Colombia, Germany, Hong Kong, Lithuania, Mexico, Netherlands, New Zealand, Peru, Philippines, Poland, Portugal, Singapore, Spain, Switzerland, Taiwan
-
Debiopharm International SAActive, not recruitingAcromegaly | GEP-NETUnited Kingdom, France, Spain, Italy, Poland, Denmark, Germany, Israel
-
Opthea LimitedRecruitingNeovascular Age-related Macular DegenerationUnited States, Argentina, Australia, Brazil, Bulgaria, Canada, Colombia, Czechia, Denmark, France, Germany, Greece, Hungary, India, Israel, Italy, Korea, Republic of, Latvia, Malaysia, Poland, Spain, Thailand, Ukraine, United Kingdom
-
Opthea LimitedActive, not recruitingNeovascular Age-related Macular DegenerationUnited States, Argentina, Australia, Austria, Brazil, Bulgaria, Canada, Colombia, Croatia, Czechia, Denmark, Estonia, France, Germany, Greece, Hungary, India, Israel, Italy, Korea, Republic of, Latvia, Lithuania, Netherlands, Philippines and more
-
Hoffmann-La RocheActive, not recruitingNeovascular Age-related Macular DegenerationUnited States, Korea, Republic of, United Kingdom, Japan, Canada, Turkey, Argentina, Australia, Denmark, France, Germany, Hungary, Italy, Poland, Spain, Singapore, Austria, Brazil, Hong Kong, Israel, Portugal, Russian Federation, Ta... and more
-
Novartis PharmaceuticalsCompletedNeovascular (Wet) Age-related Macular DegenerationGermany, Switzerland, Netherlands
-
University of UlmActive, not recruitingPrimary Myelofibrosis | Secondary Myelofibrosis | Post-PV MF | PMF | SMF | Post-ET MFGermany
-
ThromboGenicsCompletedExudative Age-Related Macular Degeneration | Focal Vitreomacular AdhesionUnited States, United Kingdom, Germany, France, Belgium, Italy